Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors. Its structure allows for selective modification in drug design, making it valuable in creating compounds with targeted biological activity. Commonly employed in research settings for optimizing potency and selectivity in small molecule therapeutics. Also utilized in the preparation of proteolysis-targeting chimeras (PROTACs) due to its bifunctional linker capabilities. Suitable for applications requiring controlled release of amine functionalities through cleavage of the carbamate group.